Cancer Research Technology
Log in Register
Menu

Recombinant, super stable IgM, anti-blood group B antibody

Invented by Tomasz Klaus , Monika Bzowska , Joanna Bereta
Invented at Jagiellonian University

Info

Catalogue Number 160644
Applications ELISA Fn WB
Antigen/Gene or Protein Targets Human blood group B antigen
Reactivity Human
Relevance Adapted from Klaus et al Sci Rep. 2018 Jan 11;8(1):519.

IgM is a multivalent antibody which evolved as a first line defense of adaptive immunity. It consists of heavy and light chains assembled into a complex oligomer. In mouse serum there are two forms of IgM, a full-length and a truncated one. The latter contains μ' chain, which lacks a variable region. Although μ' chain was discovered many years ago, its origin has not yet been elucidated. The inventing PI's results indicate that μ' chain is generated from a full-length heavy chain by non-enzymatic cleavage of the protein backbone. The cleavage occurred specifically after Asn209 and is prevented by mutating this residue into any other amino acid. The process requires the presence of other proteins, preferentially with an acidic isoelectric point, and is facilitated by neutral or alkaline pH. This unique characteristic of the investigated phenomenon distinguishes it from other, already described, Asn-dependent protein reactions. A single IgM molecule is able to bind up to 12 epitopes via its antigen binding fragments (Fabs). The cleavage at Asn209 generates truncated IgM molecules and free Fabs, resulting in a reduced IgM valence and probably affecting IgM functionality in vivo.
Host Mouse
Immunogen Human red blood cells
Subclass IgM
Research Area Other
Immunogen UniProt ID various
Recommended Growing Conditions The recombinant IgM is transiently expressed in HEK293 cells
Notes Anti-blood group B antigen antibodies have applications in medicine, especially medical diagnostics, in particular blood group determination. The commonly used antibody for such work is the parental version of this recombinant antibody. However, being prone to cleaved, especially at elevated temperatures makes the parental version much less desirable than this super stable recombinant variant.

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Klaus et al. 2018. Sci Rep. 8(1):519. PMID: 29323348.

ELISA Fn WB

IgM with improved stability and method for obtaining it and applications

ELISA Fn WB


Add a reference

References: 2 entries

Klaus et al. 2018. Sci Rep. 8(1):519. PMID: 29323348.

ELISA Fn WB

IgM with improved stability and method for obtaining it and applications

ELISA Fn WB


Add a reference

Inventor Information

Inventors

Tomasz Klaus

Tomasz Klaus

Monika Bzowska

Monika Bzowska

Joanna Bereta

Joanna Bereta

Add an inventor